ImmuCell Corporation Increase (Decrease) in Operating Capital
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Operating Capital of -$1.29 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2017-11-13
- ImmuCell Corporation increase (decrease) in operating capital for the quarter ending 2017-09-30 was $423.85K, a 157.52% increase year-over-year.
- ImmuCell Corporation increase (decrease) in operating capital for the quarter ending 2017-06-30 was -$2.11M.
- ImmuCell Corporation increase (decrease) in operating capital for the quarter ending 2017-03-31 was $399.54K.
- ImmuCell Corporation increase (decrease) in operating capital for the quarter ending 2016-12-31 was -$1.08M, a 3075.50% decline year-over-year.
- ImmuCell Corporation increase (decrease) in operating capital for fiscal 2016 was -$1.25M, a 599.59% decline from fiscal 2015.
- ImmuCell Corporation increase (decrease) in operating capital for fiscal 2015 was $249.87K.
- ImmuCell Corporation increase (decrease) in operating capital for fiscal 2014 was -$227.89K.
| Period end | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 6 month | Increase (Decrease) in Operating Capital 9 month | Increase (Decrease) in Operating Capital 12 month |
|---|---|---|---|---|
| 2017-09-30 | $423.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$1.69M derived: sum of 2 quarters · filed 2017-11-13 | -$1.29M 10-Q · filed 2017-11-13 | -$2.37M derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-06-30 | -$2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$1.71M 10-Q · filed 2017-08-14 | -$2.79M derived: sum of 3 quarters · filed 2017-08-14 | -$2.63M derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | $399.54K 10-Q · filed 2017-05-11 | -$685.18K derived: sum of 2 quarters · filed 2017-05-11 | -$520.59K derived: sum of 3 quarters · filed 2017-05-11 | -$748.13K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$920.13K derived: sum of 2 quarters · filed 2017-03-30 | -$1.15M derived: sum of 3 quarters · filed 2017-03-30 | -$1.25M 10-K · filed 2017-03-30 |
| 2016-09-30 | $164.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$62.96K derived: sum of 2 quarters · filed 2016-11-10 | -$163.63K 10-Q · filed 2016-11-10 | -$127.18K derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | -$227.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$328.22K 10-Q · filed 2016-08-11 | -$291.77K derived: sum of 3 quarters · filed 2016-08-11 | -$269.12K derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | -$100.68K 10-Q · filed 2016-05-11 | -$64.22K derived: sum of 2 quarters · filed 2016-05-11 | -$41.58K derived: sum of 3 quarters · filed 2016-05-11 | -$2.39K derived: sum of 4 quarters · filed 2016-05-11 |
| 2015-12-31 | $36.45K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $59.10K derived: sum of 2 quarters · filed 2016-03-25 | $98.28K derived: sum of 3 quarters · filed 2016-03-25 | $249.87K 10-K · filed 2016-03-25 |
| 2015-09-30 | $22.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $61.83K derived: sum of 2 quarters · filed 2015-11-12 | $213.42K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $39.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $190.77K 10-Q · filed 2015-08-13 | ||
| 2015-03-31 | $151.59K 10-Q · filed 2015-05-12 | |||
| 2014-12-31 | -$227.89K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |